Mikhail Savitski studied mathematics and physics at Uppsala University, where he also did his PhD in ion physics/mass spectrometry. After his PhD he worked at a biotechnology company Cellzome as Group Leader in the Analytical Sciences department using proteomics to aid drug discovery. Since 2016 he works at EMBL heading a research group working on stability proteomics. He develops novel proteomics technologies and uses them to study protein homeostasis, cell cycle, and regulation of disordered proteins. He has developed technologies for proteome-wide analysis of protein thermal stability as well as for monitoring changes in protein synthesis and degradation rates following cellular perturbations. He is an author of more than 60 peer reviewed publications including Cell, Nature, and Science.